Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b dose-finding study of M516102 for pruritus associated with atopic dermatitis
2008-001685-87Phase 2Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing M516102 dose group(s) with Placebo (2 arms). Primary endpoint: Mean change in VAS score during comparative treatment period versus baseline. Started Jun 2008; status: completed.
02
Drugs
M516102
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2008-001685-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001685-87.